Your search returned 3 results.

Results
	1.	Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials. [electronic resource] by Benza, Raymond L Gomberg-Maitland, Mardi Naeije, Robert Arneson, Carl P Lang, Irene M Producer: 20120126 In: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Pharmacokinetics of treprostinil sodium administered by 28-day chronic continuous subcutaneous infusion. [electronic resource] by Wade, Michael Baker, F Jo Roscigno, Robert DellaMaestra, Wayne Arneson, Carl P Hunt, Thomas L Lai, Allen A Producer: 20041216 In: Journal of clinical pharmacology vol. 44 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Dose proportionality of treprostinil sodium administered by continuous subcutaneous and intravenous infusion. [electronic resource] by McSwain, C Shane Benza, Ray Shapiro, Shelley Hill, Nicholas Schilz, Robert Elliott, C Gregory Zwicke, Dianne L Oudiz, Ronald J Staszewski, James P Arneson, Carl P Wade, Michael Zaccardelli, David McLaughlin, Vallerie Producer: 20080418 In: Journal of clinical pharmacology vol. 48 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)